Market Closed - London S.E. 09:05:00 24/05/2024 pm IST 5-day change 1st Jan Change
1.85 GBX +10.45% Intraday chart for genedrive plc +1.37% -77.23%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
FTSE 100 stumbles as rain dampens retail sales AN
Genedrive Wins Initial UK Orders for Hearing Loss Test for Infants MT
FTSE 100 in red as UK election heats up AN
Genedrive announces orders for testing kit worth over GBP100,000 AN
AIM WINNERS & LOSERS: Kinovo rises as results ahead of expectations AN
Genedrive plc Receives Initial Orders of the Genedrive MT-RNR1 Products for New Sites in the UK CI
CVS sells Dutch and Irish loss-making businesses AN
Genedrive Raises GBP2 Million via Share Placing MT
Genedrive completes placing portion of GBP6 million raise AN
AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing AN
Molecular Diagnostics Company Genedrive Seeks GBP8 Million Equity Raise MT
Genedrive aims to raise at least GBP6 million in share offer AN
Genedrive enters clinical trial deal in US for MT-RNR1 US approval AN
FTSE 100 up thanks to US economic data AN
Genedrive shares surge as UK's NICE backs test for ischaemic stroke AN
AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal AN
Genedrive's Test Receives Draft Recommendation from UK's NICE MT
EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate AN
Genedrive plc Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Genedrive down as plans equity raise despite GBP800,000 tax credit AN
Coro seals sale terms, Powerhouse makes good progress AN
Genedrive Seeks Funding for Testing Kit Amid Funding Call Launch of UK-backed Program MT
MoneySupermarket credits Insurance for growth in 2023 AN
Genedrive draws down GBP600,000 on prepayment facility AN
Genedrive Secures Financing Under Equity Prepayment Facility MT
Chart genedrive plc
More charts
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Calendar
More about the company

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. EHP Stock
  4. News genedrive plc
  5. Genedrive Shares Surge With UKCA Marking Registration for Pharmacogenomic Test